UK markets close in 3 hours 42 minutes
  • FTSE 100

    +16.89 (+0.24%)
  • FTSE 250

    -45.66 (-0.20%)
  • AIM

    +1.42 (+0.12%)

    +0.0013 (+0.11%)

    +0.0023 (+0.17%)

    +1,615.56 (+7.10%)
  • CMC Crypto 200

    +19.63 (+2.47%)
  • S&P 500

    +21.65 (+0.51%)
  • DOW

    +68.61 (+0.20%)

    +0.51 (+0.70%)

    +6.00 (+0.34%)
  • NIKKEI 225

    -9.24 (-0.03%)

    +507.31 (+1.79%)
  • DAX

    -108.61 (-0.69%)
  • CAC 40

    -44.75 (-0.68%)

Global Next Generation Sequencing (NGS) Market Report 2021-2026 Featuring Illumina, Thermo Fisher Scientific, Pacific Biosciences, Oxford Nanopore Technologies & Roche

·5-min read

Dublin, June 04, 2021 (GLOBE NEWSWIRE) -- The "Global Next Generation Sequencing (NGS) Market (By Products - Consumables, Platforms, Services, Sequencing Services, Bioinformatics, Technology, Applications, End Users, Regions), Impact of COVID-19, Recent Developments, Key Company Profiles - Forecast to 2026" report has been added to's offering.

The global next generation sequencing market is expected to reach nearly US$ 20 Billion by 2026.

Next generation sequencing (NGS) is a novel procedure for sequencing genomes at low costs and high speed with improved efficiency. NGS is a technology in which millions and billions of DNA strands can be sequenced through massive parallelization.

The market is driven by factors such as advancements in NGS platforms, decreasing cost of sequencing, improving regulatory & reimbursement scenario for NGS-based diagnostic tests, initiatives from government & private bodies for large-scale sequencing projects, and increasing application of NGS in precision medicine & molecular diagnostics.

In addition, rise in awareness pertaining to next generation sequencing and increase in investment in research, development, and innovation supplement the market growth. However, lack of skilled professionals, and ethical & legal limitations are projected to impede the growth of the next generation sequencing market.

Impact of COVID-19 on Global Next Generation Sequencing (NGS) Market

The COVID-19 outbreak has become a global stress test. The disease has infected over 159 Million people worldwide. Globally the death toll has reached 3,312,333 according to the latest statistics from the Worldometers (as of May 10, 2021).

The number is still growing, and the duration of the pandemic is still difficult to predict. The COVID-19 outbreak has positively impacted the next generation sequencing (NGS) market.

Next-generation sequencing has a crucial role in the clinical labs and research to fight against the SARS-CoV-2, which results in the COVID-19. Next-generation sequencing (NGS) technology has the potential advantage of determining the genetic sequence of a virus and helping scientists understand the mutation of the virus.

In June 2020, the United States Food and Drug Administration issued an emergency use authorization (EUA) to Illumina for the first COVID-19 diagnostic test utilizing next-generation sequence technology. The major factors such as increasing research and development activities utilizing the NGS technologies, growing applications of NGS in clinical diagnosis, rising prevalence of chronic diseases, and increasing demand for next generation sequencing due to COVID-19 are expected to drive the growth of the overall market.

Key Topics Covered:

1. Executive Summary

2. Impact of COVID-19 on Global Next Generation Sequencing (NGS) Market

3. Global Next Generation Sequencing (NGS) Market and Forecast (2015 - 2026)

4. Global Next Generation Sequencing (NGS) Market Share and Forecast (2015 - 2026)

5. By Products - Global Next Generation Sequencing (NGS) Market and Forecast (2015 - 2026)
5.1 By Consumables
5.2 By Platforms
5.3 By Services

6. Global Next Generation Sequencing (NGS) - Consumables Market and Forecast (2015 - 2026)
6.1 Sample Preparation Market and Forecast
6.1.1 DNA Fragmentation, End Repair, A-Tailing and Size Selection Market and Forecast
6.1.2 Library Preparation and Target Enrichment Market and Forecast
6.1.3 Quality Control Kits & Reagents Market and Forecast

7. Global Next Generation Sequencing (NGS) - Platforms Market and Forecast (2015 - 2026)
7.1 HiSeq Series Market and Forecast
7.2 MiSeq Series Market and Forecast
7.3 NextSeq Series Market and Forecast
7.4 MiniSeq Market and Forecast
7.5 NovaSeq Market and Forecast
7.6 iSeq Market and Forecast
7.7 Ion Torrent Market and Forecast
7.8 SOLiD Market and Forecast
7.9 PacBio RS II Market and Forecast
7.10 Sequel System Market and Forecast
7.11 PromethION Market and Forecast

8. Global Next Generation Sequencing (NGS) - Services Market and Forecast (2015 - 2026)
8.1 Sequencing Services Market and Forecast
8.1.1 Targeted Re-sequencing (TPS/WES) Market and Forecast
8.1.2 RNA Sequencing Market and Forecast
8.1.3 Whole Genome Sequencing Market and Forecast
8.1.4 ChIP Sequencing Market and Forecast
8.1.5 De Novo Sequencing Market and Forecast
8.1.6 Methyl Sequencing Market and Forecast
8.2 Bioinformatics Market and Forecast
8.2.1 Primary and Secondary Data Analysis Tools Market and Forecast
8.2.2 Storage Market and Forecast
8.2.3 Biological Interpretation and Reporting Tools Market and Forecast
8.2.4 Computing Market and Forecast
8.2.5 LIMS (Laboratory Information Management System) Market and Forecast
8.2.6 NGS Informatics Services Market and Forecast

9. Global Next Generation Sequencing (NGS) - Technology Market and Forecast (2015 - 2026)
9.1 Sequencing by Synthesis Market and Forecast
9.2 Ion Semiconductor Sequencing Market and Forecast
9.3 Single-molecule Real-time Sequencing Market and Forecast
9.4 Nanopore Sequencing Market and Forecast

10. Global Next Generation Sequencing (NGS) - Applications Market and Forecast (2015 - 2026)
10.1 Clinical Applications Market and Forecast
10.1.1 Reproductive Health Market and Forecast
10.1.2 Rare Disease Diagnostics Market and Forecast
10.1.3 Oncology (Cancer) Market and Forecast
10.1.4 Metabolic and Immune (Diagnostic) Market and Forecast
10.1.5 Cardiovascular Market and Forecast
10.2 Global Next Generation Sequencing (NGS) - Research Applications & Others Market and Forecast

11. Global Next Generation Sequencing (NGS) - End Users Market and Forecast (2015 - 2026)
11.1 Academic Research Market and Forecast
11.2 Hospitals Market and Forecast
11.3 Biotech/Pharma Market and Forecast
11.4 Government Market and Forecast

12. Global Next Generation Sequencing (NGS) - Regional Market and Forecast (2015 - 2026)

13. Global Next Generation Sequencing Market - Recent Developments

14. Global Next Generation Sequencing Market - Company Profiles
14.1 Illumina
14.2 Thermo Fisher Scientific
14.3 Pacific Biosciences
14.4 Oxford Nanopore Technologies
14.5 Roche

15. Global Next Generation Sequencing Market - Growth Drivers
15.1 Increasing Adoption of NGS in Clinical Application
15.2 Advancement in Next Generation Sequencing Platforms
15.3 Increasing Prevalence of Cancer Cases Driving the Market of Next Generation Sequencing

16. Global Next Generation Sequencing Market - Challenges
16.1.1 Lack of skilled professional

For more information about this report visit

CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting